SATB1 and prostate carcinoma: In this study, we constructed oncolytic adenovirus carrying SATB1 named as Ad-ZD55-SATB1 (ZD55-SATB1) and combined it with chemotherapeutic drug DTX to explore the effects on proliferation, invasion, and apoptosis of prostate cancer cells in vitro and in vivo.